Consequences of chronic extracochlear electrical stimulation in neonatally deafened cats.
This investigation examined the consequences of neonatal deafness and chronic electrical stimulation of the cochlea in the developing auditory system. Cats were bilaterally deafened by daily ototoxic drug administration for two weeks after birth. Electrical stimulation was initiated at 6-9 weeks of age and continued for up to 6 months, using monopolar round window electrodes that synchronously excited auditory neurons throughout the cochlea. Morphometric evaluation of the density of spiral ganglion cell somata within Rosenthal's canal demonstrated that chronic stimulation induced an increase of about 6% in neuronal survival. Although this difference was statistically significant, extracochlear stimulation in these cats was less effective in preventing neural degeneration than lower intensity, more restricted intracochlear stimulation that was shown in a previous study to induce an average increase of about 13% in neuronal survival. Electrophysiological recording experiments conducted in the inferior colliculus in these animals indicated that monopolar extracochlear stimulation can induce profound alterations in the spatial (frequency) selectivity of the auditory midbrain. On average, results were similar to those previously reported for bipolar intracochlear stimulation, showing about a two-fold expansion of the central representation of chronically stimulated electrodes. However, results with extracochlear stimulation showed much greater variability among individual animals. The results presented suggest that it is problematic to effect consistent 'whole' nerve stimulation using monopolar round window electrodes. Moreover, this mode of stimulation can induce profound functional alterations in the central nervous system and is substantially less effective in forestalling the degeneration of auditory neurons than intracochlear stimulation. Both these results contraindicate the implantation of such electrodes in young children for the purpose of maintaining the integrity of the auditory system for later application of a multichannel cochlear implant.
Leake
P A
PA
Department of Otolaryngology, University of California San Francisco 94143-0526, USA.
Snyder
R L
RL
Hradek
G T
GT
Rebscher
S J
SJ
D000818:Animals; D000831:Animals, Newborn; D001303:Auditory Cortex / Q000502:physiology*; D001309:Auditory Threshold / Q000502:physiology; D002415:Cats; D003051:Cochlea / Q000166:cytology / Q000502:physiology; D003054:Cochlear Implants; D003638:Deafness / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology*; D004558:Electric Stimulation; D004594:Electrophysiology; D007245:Inferior Colliculi / Q000502:physiology; D008854:Microscopy, Electron; D009355:Neomycin / Q000008:administration & dosage / Q000633:toxicity; D009474:Neurons / Q000502:physiology / Q000648:ultrastructure; D013136:Spiral Ganglion / Q000166:cytology / Q000502:physiology / Q000648:ultrastructure*
D009355:Neomycin